ko pathway ratio_in_study ratio_in_pop p_value ko04060 Cytokine-cytokine receptor interaction 8/48 191/7206 3.19856884573e-05 ko04668 TNF signaling pathway 6/48 120/7206 0.000130394412394 ko04064 NF-kappa B signaling pathway 5/48 96/7206 0.000411359691695 ko04933 AGE-RAGE signaling pathway in diabetic complications 5/48 135/7206 0.00192222171223 ko04657 IL-17 signaling pathway 4/48 87/7206 0.002573342009 ko05323 Rheumatoid arthritis 4/48 89/7206 0.00279545660691 ko05144 Malaria 3/48 45/7206 0.00323503438875 ko05219 Bladder cancer 3/48 48/7206 0.00388847493818 ko04350 TGF-beta signaling pathway 4/48 103/7206 0.00472949487151 ko04068 FoxO signaling pathway 5/48 167/7206 0.00482039641878 ko05321 Inflammatory bowel disease (IBD) 3/48 56/7206 0.00600453561917 ko05206 MicroRNAs in cancer 5/48 177/7206 0.00615672806643 ko05142 Chagas disease (American trypanosomiasis) 4/48 130/7206 0.0106620984227 ko04380 Osteoclast differentiation 4/48 134/7206 0.0118224003087 ko04214 Apoptosis - fly 3/48 72/7206 0.0119955201015 ko04931 Insulin resistance 4/48 137/7206 0.0127441549999 ko05212 Pancreatic cancer 3/48 83/7206 0.0175645832644 ko04672 Intestinal immune network for IgA production 2/48 37/7206 0.0249531211092 ko05132 Salmonella infection 3/48 98/7206 0.0271351387832 ko04218 Cellular senescence 4/48 177/7206 0.0295841797078 ko04932 Non-alcoholic fatty liver disease (NAFLD) 4/48 182/7206 0.0323178905801 ko04659 Th17 cell differentiation 3/48 106/7206 0.0331771675106 ko05205 Proteoglycans in cancer 5/48 271/7206 0.033227924057 ko05200 Pathways in cancer 7/48 492/7206 0.0427347541285 ko04066 HIF-1 signaling pathway 3/48 123/7206 0.0481474648657